NCT07365176Completed
High-intensity Interval Exercise Compared With Continuous Moderate Exercise on Glycemia in Postabsorptive vs. Postprandial State in Adults With Type 1 Diabetes
The Protective Role of High-intensity Interval Exercise Compared With Continuous Moderate Exercise on Glycemia Decrease is More Relevant in Postabsorptive vs. Postprandial State in Adults With Type 1 Diabetes
Source: ClinicalTrials.gov · Last updated 26 Jan 2026
Brief summary (registry, in English)
This randomized crossover trial examined whether exercise modality (high-intensity interval exercise vs. moderate-intensity continuous exercise) and timing relative to meals (postprandial vs. postabsorptive) influence glycemic responses in physically active adults with type 1 diabetes. Participants completed four cycling sessions matched for total mechanical load, and glucose levels were monitored during exercise and for 24 hours afterward while accounting for dietary intake and insulin administration. The study hypothesized that glycemic responses differ according to both exercise type and prandial state.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 21 (actual)
- First submitted
- 28 Dec 2025
- Start date
- 8 Feb 2023
- Primary completion date
- 17 Jan 2025
- Lead sponsor
- Universite du Littoral Cote d'Opale
- Diseases
- Type 1 diabetes
- NCT number
- NCT07365176
What you commit to
- Study type: Interventional
- Participants enrolled: 21
- From 8 Feb 2023 to the primary completion date, 17 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diabetes-related complications except for background retinopathy
Who the study is looking for
- Between 18 and 60 years of age
- Regular practice of physical activity (at least 2 training sessions/week for at least 3 months)
- Diagnosis of type 1 diabetes for \>1 year
- No change in insulin delivery method (i.e., multiple daily injections \[MDI\], continuous subcutaneous insulin infusion \[CSII\] in open or closed loop) over the previous 3 months
- Use of a continuous glucose monitoring (CGM) device in daily life
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Unité de Recherche Pluridisciplinaire Sport, Santé, Société (URePSSS - ULR 7369) Coordinator of this site? Confirm its status | Loos | France | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.